Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marconi

Showing results (331-340 of 393) with videos related to

Pageof 40
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2021
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency VirusVincent C Marconi, Carlee Moser, Christina Gavegnano, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Vaccine|July 10, 2026
COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemicTaing Nandi Aung, Winnie Muyindike, Susanne S Hoeppner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational StudyAnthony N Muiru, Erin Madden, Rebecca Scherzer, et al.
Addiction Science & Clinical Practice|July 31, 2020
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
HIV Medicine|November 10, 2021
Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South AfricaZahra Reynolds, Suzanne M McCluskey, Mahomed Yunus S Moosa, et al.
Open Forum Infectious Diseases|August 11, 2022
Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016-2019Neha Balachandran, Jordan Cates, Anita K Kambhampati, et al.
The Lancet. Respiratory Medicine|September 4, 2021
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trialVincent C Marconi, Athimalaipet V Ramanan, Stephanie de Bono, et al.
Plos Pathogens|August 27, 2021
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ARTMaria Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, et al.
The Lancet. HIV|May 22, 2019
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
Pageof 40

Showing results (331-340 of 393) with videos related to

Sort By:
Pageof 40
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2021
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency VirusVincent C Marconi, Carlee Moser, Christina Gavegnano, et al.
Nature Medicine|April 1, 2008
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individualsSunil K Ahuja, Hemant Kulkarni, Gabriel Catano, et al.
Vaccine|July 10, 2026
COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemicTaing Nandi Aung, Winnie Muyindike, Susanne S Hoeppner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational StudyAnthony N Muiru, Erin Madden, Rebecca Scherzer, et al.
Addiction Science & Clinical Practice|July 31, 2020
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
HIV Medicine|November 10, 2021
Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South AfricaZahra Reynolds, Suzanne M McCluskey, Mahomed Yunus S Moosa, et al.
Open Forum Infectious Diseases|August 11, 2022
Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016-2019Neha Balachandran, Jordan Cates, Anita K Kambhampati, et al.
The Lancet. Respiratory Medicine|September 4, 2021
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trialVincent C Marconi, Athimalaipet V Ramanan, Stephanie de Bono, et al.
Plos Pathogens|August 27, 2021
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ARTMaria Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, et al.
The Lancet. HIV|May 22, 2019
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
Pageof 40